Advanced glycation end products in nephrology
Author(s)
Bibliographic Information
Advanced glycation end products in nephrology
(Contributions to nephrology, v. 131)
Karger, 2001
Available at 3 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographical references and indexes
Description and Table of Contents
Description
The pathological role of advanced glycation end products (AGEs) and of oxidative-carbonylic stress is well known in the context of diabetes. Moreover, there is also strong evidence that they play a pivotal role in the pathogenesis of some chronic disorders related to uremia, and namely to cardiovascular complications and dialysis-related amyloidosis. They may even play a crucial role in the loss of function of the peritoneal membrane in patients on peritoneal dialysis, a problem which limits the duration of such a treatment. Written by some of the most authoritative European experts, this publication includes up-to-date contributions on AGEs as related to diabetic nephropathy, hemodialysis and, particularly, peritoneal dialysis. The topics covered range from basic research (e.g. novel pathogenic pathways triggered by AGEs) to clinical issues, including substitutive therapy in uremic diabetic patients as well as original and new results from a clinical trial on peritoneal dialysis with a new bag. This publication will be of interest to nephrologists as well as those working in the field of diabetes or otherwise involved in AGE research, giving an idea into what direction research in this complex field is going and which will probably be the major clinical breakthroughs in the near future.
Table of Contents
- Chemistry and pathobiology of advanced glycation end products, E.D. Schleicher et al
- AGE in micro- and macroangiopathy, A. Lapolla et al
- diabetic nephropathy and advanced glycation end products, P. Men et al
- hemodialysis techniques and advanced glycation end products, N. Tessitore et al
- diabetic uraemia and haemodialytic treatments, A. Naso, et al
- peritoneal Dialysis in diabetic patients, M. Bertoli, et al
- molecular biology of the peritoneal membrane - in between morphology and function, F. Anglani et al
- peritoneal transport in long-term peritoneal dialysis patients and its relation with AGEs, M. Feriani
- exogenous uptake of carbonyl stress compounds promoting AGE formation from peritoneal dialysis fluids, A. Wieslander et al
- the dialytic failure of the peritoneal membrane, A. Lupo et al
- a peritoneal dialysis solution prepared from a three-compartment bag - biological and clinical effects, G. Capelli et al
- inhibition of transforming growth factor-b1 gene overexpression as a strategy to prevent fibrosis, G. Gambaro et al. Strategy for Preventing Peritoneal Dialysis Failure: Cancarini, G
- clinical research in peritoneal dialysis, G.A. Coles
- contribution of the mesangium to elastic strength and anchorage of the glomerular capillary tuft, R.B. Sterzel et al.
by "Nielsen BookData"